A randomized, waiting list-controlled 12-week trial of atomoxetine in adults with ADHD

Pharmacopsychiatry

Volumn 45, Issue 3, 2012, Pages 100-107

  Sobanski, E ^a   Sabljic, D ^a   Alm, B ^a   Baehr, C ^a   Dittmann, R W ^a   Skopp, G ^a   Strohbeck Kuehner, P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

adult attention deficit hyperactivity disorder; atomoxetine; quality of life; self esteem

Indexed keywords

ATOMOXETINE;

ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DECREASED APPETITE; DEPRESSION; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; DSM-IV; ERECTILE DYSFUNCTION; FATIGUE; FEMALE; HEART PALPITATION; HUMAN; HYPERHIDROSIS; IRRITABILITY; LIFE SATISFACTION; LIMB DYSESTHESIA; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SELF CONCEPT; SIDE EFFECT; SKIN ALLERGY; TREATMENT RESPONSE; URINARY HESITANCY; XEROSTOMIA;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROPYLAMINES; QUALITY OF LIFE; SELF CONCEPT; TREATMENT OUTCOME; WAITING LISTS; YOUNG ADULT;

EID: 84861230954     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0031-1291319     Document Type: Article

References (35)

1. Fayyad J, De Graaf R, Kessler R et al. Cross-national prevalence and correlates of adult attention-deficit /hyperactivity disorder. Br J Psychiatry: 2007; 190 402 409 (Pubitemid 46706952)
2. Kessler R C, Adler L, Barkley R et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry: 2006; 163 716 723 (Pubitemid 44464584)
3. th edn revised. Washington, DC American Psychiatric Press: 2000
4. Rösler M, Retz W, Fischer R et al. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry: 2010; 11 709 718
5. Reimherr F W, Marchant B K, Strong R E et al. Emotional dysregulation in adult ADHD and response to atomoxetine. Biol Psychiatry: 2005; 58 125 131 (Pubitemid 41008129)
6. Reimherr F W, Williams E D, Strong R E et al. A double-blind crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry: 2007; 68 93 101 (Pubitemid 46220130)
7. Safren S A, Sprich S, Perlman C A et al. Mastering your adult ADHD: a cognitive-behavioral therapy treatment program. Therapist Guide. New York Oxford University Press: 2005
8. Barkley R A. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry: 2002; 63 10 15 (Pubitemid 36025582)
9. Brod M, Perwien A, Adler L et al. Conceptualization and assessment of quality of life for adults with attention-deficit/hyperactivity disorder. Prim Psychiatry: 2005; 12 58 64 (Pubitemid 40847559)
10. Matza L S, Johnston J A, Faries D E et al. Responsiveness of the Adult ADHD Quality of Life Scale. Qual Life Res: 2007; 16 1511 1520
11. Mick E, Faraone S V, Spencer T et al. Assessing the validity of the Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form in adults with ADHD. J Atten Dis: 2008; 11 504 508
12. Adler L A, Sutton V K, Moore R J et al. Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine. J Clin Psychopharmcol: 2006; 26 648 652 (Pubitemid 44772744)
13. Spencer T, Biederman J, Wilens T et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry: 1998; 155 693 695 (Pubitemid 28225414)
14. Michelson D, Adler L, Spencer T et al. Atomoxetine in adults with ADHD: two randomized placebo-controlled studies. Biol Psychiatry: 2003; 53 112 120 (Pubitemid 36126473)
15. Takahashi M, Takita Y, Goto T et al. An open-label dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci: 2011; 65 55 63
16. Conners C K, Erhardt D, Sparrow E P. Conners' Adult ADHD Rating Scales (CAARS). North Tonawanda Multi-Health Systems: 1999
17. Medori R, Ramos-Quiroga J A, Casas M et al. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry: 2008; 63 981 989
18. Christiansen H, Kis B, Hirsch O et al. German validation of the Conners Adult ADHD Rating Scales-Self-report (CAARS-S) I: Factor structure and normative data. Eur Psychiatry: 2010; 26 100 107
19. Roesler M, Retz W, Retz-Junginger P et al. Instrumente zur Diagnostik der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter Selbstbeurteilungsskala (ADHS-SB) und Diagnosecheckliste (ADHS-DC). Nervenarzt: 2004; 75 888 895 (Pubitemid 39312514)
20. Retz-Junginger P, Retz W, Blocher D et al. Wender Utah Rating Scale (WURS-k). Die deutsche Kurzform zur retrospektiven Erfassung des hyperkinetischen Syndroms bei Erwachsenen. Nervenarzt: 2002; 73 830 838 (Pubitemid 36062318)
21. Hautzinger M, Bailer M, Worall H et al. Beck-Depressions-Inventar (BDI). Bearbeitung der deutschen Ausgabe. Testhandbuch. Göttingen Huber: 1994
22. Wender P H. Attention-deficit hyperactivity disorder in adults. New York Oxford University Press: 1994
23. Rösler M, Retz-Junginger P, Retz W et al. HASE - Homburger ADHS Skalen für Erwachsene. Göttingen Hogrefe: 2008
24. Wittchen H U, Wunderlich U, Gruschwitz S et al. Strukturiertes klinisches Interview für DSM-V (SKID-I). Göttingen Hogrefe: 1997
25. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest: Form B. Erlangen Straube: 1997
26. Endicott J, Nee J, Harrison W et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull: 1993; 29 321 326 (Pubitemid 23311543)
27. Ritsner M, Kurs R, Gibel A et al. Validity of an abbreviated Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Qual Life Res: 2005; 14 1693 1703 (Pubitemid 40978478)
28. Johnson M, Cederlund M, Rastam M et al. Open-label treatment of atomoxetine hydrochloride in adults with ADHD. J Atten Disord: 2010; 13 539 545
29. Adler L, Goodman D W, Kollins S H et al. Double-blind, placebo controlled study of the efficacy and safety of lisdexamfetamine dismesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry: 2008; 69 1364 1374
30. Faraone S V, Glatt S J. A comparison of medications for adult ADHD using meta-analysis of effect sizes. J Clin Psychiatry: 2010; 71 754 763
31. Meszaros A, Czobor P, Balint S et al. Pharmacotherapy of adult ADHD: a meta-analysis. Int J Neuropsychopharmacol: 2009; 12 1137 1147
32. Rosenberg M. Society and the adolescent self-image. Princeton, NJ Princeton University Press: 1965
33. Brown R T, Perwien A, Faries D E et al. Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning. Clin Pediatr: 2006; 45 819 827 (Pubitemid 44570029)
34. Perwien A R, Faries D E, Kratochvil C J et al. Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine. J Dev Behav Pediatr: 2004; 25 264 271 (Pubitemid 39199572)
35. Jain U, Hechtman L, Weiss M et al. Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with ADHD: results of a double-blind, placebo-controlled crossover study. J Clin Psychiatry: 2007; 68 268 277 (Pubitemid 46362649)